1 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Efficacy and Safety of Rifaximin in Treating MAFLDMetabolic-associated Fatty Liver DiseaseRecruitingEarly phase 12025-09-22NCT07185932